Intravenous immunoglobulin for infectious diseases: Back to the pre-antibiotic and passive prophylaxis era?

Jagadeesh Bayry, Sébastien Lacroix-Desmazes, Michel D. Kazatchkine, Srini V. Kaveri

科研成果: 期刊稿件文章

71 引用 (Scopus)

摘要

The dramatic increase in both the number of novel infectious agents and resistance to antimicrobial drugs has incited the need for adjunct therapies in the war against infectious diseases. Exciting recent studies have demonstrated the use of antibodies in the form of intravenous immunoglobulin (IVIg) against infections. By virtue of the diverse repertoire of immunoglobulins that possess a wide spectrum of antibacterial and antiviral specificities, IVIg provides antimicrobial efficacy independently of pathogen resistance and represents a promising alternative strategy for the treatment of diseases for which a specific therapy is not yet available.
源语言英语
期刊Trends in Pharmacological Sciences
25
6
DOI
已出版 - 1 一月 2004

指纹 探究 'Intravenous immunoglobulin for infectious diseases: Back to the pre-antibiotic and passive prophylaxis era?' 的科研主题。它们共同构成独一无二的指纹。

  • 引用此